AHS 2020: Patients With Migraine Headache Who Switch From Erenumab to Galcanezumab Report Similar Improvement
Lack of efficacy is the most common reason for discontinuation with both drugs.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.